BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  NCCN Announces Funding for Research on Multiple Myeloma Treatment

  The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced grants awarded to support clinical studies that will evaluate the efficacy and safety of elranatamab in the treatment of multiple myeloma.

  December 19, 2023

   · 

  3 min read
• Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024

  Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024.

  December 19, 2023

   · 

  1 min read
• Business

  Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors

  Endeavor BioMedicines announced that the company has appointed Enoch Kariuki, Pharm.D. to the Endeavor BioMedicines Board of Directors.

  December 19, 2023

   · 

  2 min read
• Genetown

  Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

  Inhibikase Therapeutics, Inc. today issued a Letter to Shareholders.

  December 19, 2023

   · 

  6 min read
• Drug Development

  MBrace Therapeutics Announces Initiation of Patient Dosing in Phase 1 Clinical Trial Evaluating Investigational Antibody-Drug Conjugate MBRC-101

  MBrace™ Therapeutics, Inc. today announced the successful initiation of patient dosing in its Phase 1/1b study evaluating MBRC-101 in patients with advanced metastatic solid tumors refractory to standard treatment.

  December 19, 2023

   · 

  3 min read
• Business

  Neogen Announces Second-Quarter Earnings Release Date - December 19, 2023

  Neogen Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on Tuesday, January 9, 2024.

  December 19, 2023

   · 

  1 min read
• Deals

  NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split

  NeuroBo Pharmaceuticals, Inc. today announced a 1-for-8 reverse stock split of the Company’s Common Stock, par value $0.001.

  December 19, 2023

   · 

  5 min read
• Life Science Instrumentation Market Size To Hit USD 112.96 Billion By 2032

  Latest Study on “Life Science Instrumentation Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2023-2032”.

  December 19, 2023

   · 

  9 min read
• Austrianova reports successful metronomic treatment using Cell-in-a-Box® in an an-imal model of pancreatic cancer

  Austrianova, a member of the SGAustria group of companies, and a leading provider of cell encapsulated products as well as other biological products and services,

  December 19, 2023

   · 

  4 min read
• Pharm Country

  The Cigna Group Announces Appearance at the 42nd Annual J.P. Morgan Healthcare Conference

  Global health company The Cigna Group (NYSE:CI) announced today that David Cordani, chairman and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 in San Francisco, CA.

  December 19, 2023

   · 

  1 min read